South Korea to buy 70,000 programs of latest Pfizer COVID-19 capsule
SEOUL – South Korea has agreed to buy 70,000 courses of Pfizer Inc.’s experimental antiviral COVID-19 pill, the Korea Disease Control and Prevention Agency (KDCA)...
If it ain’t broke, don’t repair it
“Different countries were interested in our stock exchange,” reminisces former Securities and Exchange Commission chairman Khalid Mirza. “I met a representative, who I will...
Makers misplaced their footing after Pfizer’s COVID-19 antiviral tablet confirmed promising efficacy in a...
Hong Kong stocks declined for a second day with tech firms leading losers as the Chinese Communist Party kicked off a key meeting in Beijing under...
